# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000899923-22-000057
Filing Date
2022-04-14
Accepted
2022-04-14 16:06:00
Documents
57
Period of Report
2022-06-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | a2022proxystatement.htm | DEF 14A | 1340159
2 |  | afc.jpg | GRAPHIC | 35720
3 |  | afc2.jpg | GRAPHIC | 36612
4 |  | afcchairbiggerc.jpg | GRAPHIC | 14924
5 |  | afcchairiconbigger.jpg | GRAPHIC | 18557
6 |  | afcicon.jpg | GRAPHIC | 3449
7 |  | afcicon3.jpg | GRAPHIC | 3830
8 |  | atthemeeting.jpg | GRAPHIC | 11400
9 |  | byinternetorphone.jpg | GRAPHIC | 29301
10 |  | byml.jpg | GRAPHIC | 17974
11 |  | chart-104fb895a3e740db9d8.jpg | GRAPHIC | 60647
12 |  | chart-47b8399c07a04c81b6a.jpg | GRAPHIC | 72175
13 |  | chart-547ff38dfda04f2eac9.jpg | GRAPHIC | 61199
14 |  | chart-88830f8e6ae4437cbcd.jpg | GRAPHIC | 128607
15 |  | chcc.jpg | GRAPHIC | 41078
16 |  | chccchairbiggerc.jpg | GRAPHIC | 43598
17 |  | chccchairiconbigger.jpg | GRAPHIC | 14564
18 |  | chccicon.jpg | GRAPHIC | 3297
19 |  | dreis.jpg | GRAPHIC | 9436
20 |  | eric-santa_2021.jpg | GRAPHIC | 201153
21 |  | image.jpg | GRAPHIC | 44720
22 |  | image1.jpg | GRAPHIC | 22075
23 |  | image3.jpg | GRAPHIC | 186855
24 |  | image_2.jpg | GRAPHIC | 2930
25 |  | jayne-hartx2021xe164097682.jpg | GRAPHIC | 549260
26 |  | kevin-haas_2021.jpg | GRAPHIC | 201324
27 |  | langer.jpg | GRAPHIC | 9448
28 |  | maggie-ancona_2021.jpg | GRAPHIC | 174572
29 |  | mark-verratti_2021.jpg | GRAPHIC | 202811
30 |  | matrix-diagnostic.jpg | GRAPHIC | 3305
31 |  | matrix-diversity.jpg | GRAPHIC | 5682
32 |  | matrix-healthcare.jpg | GRAPHIC | 3365
33 |  | matrix-leadership.jpg | GRAPHIC | 4468
34 |  | matrix-publiccogov.jpg | GRAPHIC | 3718
35 |  | matrix-researchdev.jpg | GRAPHIC | 3251
36 |  | matrix-tech.jpg | GRAPHIC | 4024
37 |  | muzzey_headshot2a.jpg | GRAPHIC | 95024
38 |  | myriad_logoxstackedpreferr.jpg | GRAPHIC | 623142
39 |  | nesgc.jpg | GRAPHIC | 49996
40 |  | nesgcchairbiggerc.jpg | GRAPHIC | 17412
41 |  | nesgcicon.jpg | GRAPHIC | 3342
42 |  | nesgciconbigger.jpg | GRAPHIC | 16192
43 |  | newcomer.jpg | GRAPHIC | 8694
44 |  | nicole-lambert_2021.jpg | GRAPHIC | 176277
45 |  | pamela-wongx300x300x1.jpg | GRAPHIC | 21559
46 |  | paul-diaz_2021.jpg | GRAPHIC | 197501
47 |  | phan.jpg | GRAPHIC | 9158
48 |  | proxycardc4_page1a.jpg | GRAPHIC | 112678
49 |  | proxycardc4_page2a.jpg | GRAPHIC | 124899
50 |  | rashmi-kumara.jpg | GRAPHIC | 31424
51 |  | reitan.jpg | GRAPHIC | 8580
52 |  | rpic.jpg | GRAPHIC | 44177
53 |  | rpicchairbiggerc002.jpg | GRAPHIC | 69842
54 |  | rpicchairiconbigger.jpg | GRAPHIC | 21337
55 |  | rpicicon.jpg | GRAPHIC | 3906
56 |  | skov.jpg | GRAPHIC | 11736
57 |  | spieg.jpg | GRAPHIC | 11559
| Complete submission text file | 0000899923-22-000057.txt |  | 6674508

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26642 | Film No.: 22827298
SIC: 2835 In Vitro & In Vivo Diagnostic Substances